Oruka Therapeutics, Inc. ORKA Issuance Of Common Stock Series A Nonvoting Convertible Preferred Stock And Prefunded Warrants In Connection With Pipe Financing
Issuance Of Common Stock Series A Nonvoting Convertible Preferred Stock And Prefunded Warrants In Connection With Pipe Financing at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:IssuanceOfCommonStockSeriesANonvotingConvertiblePreferredStockAndPrefundedWarrantsInConnectionWithPipeFinancing.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s issuance of common stock series a nonvoting convertible preferred stock and prefunded warrants in connection with pipe financing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s issuance of common stock series a nonvoting convertible preferred stock and prefunded warrants in connection with pipe financing?
- Oruka Therapeutics, Inc. (ORKA) reported issuance of common stock series a nonvoting convertible preferred stock and prefunded warrants in connection with pipe financing of $144.44M in Q4 2024.
- What does issuance of common stock series a nonvoting convertible preferred stock and prefunded warrants in connection with pipe financing mean?
- Represents the aggregate value of capital raised through the issuance of complex equity instruments, including non-voting convertible preferred stock and pre-funded warrants. This highlights the company's strategy for raising growth capital while managing voting control and dilution.